A subscription to JoVE is required to view this content. Sign in or start your free trial.
The present protocol describes the porcine fascio-cutaneous flap model and its potential use in vascularized composite tissue research.
Vascularized Composite Allografts (VCA) such as hand, face, or penile transplant represents the cutting-edge treatment for devastating skin defects, failed by the first steps of the reconstructive ladder. Despite promising aesthetic and functional outcomes, the main limiting factor remains the need for a drastically applied lifelong immunosuppression and its well-known medical risks, preventing broader indications. Therefore, lifting the immune barrier in VCA is essential to tip the ethical scale and improve patients' quality of life using the most advanced surgical techniques. De novo creation of a patient-specific graft is the upcoming breakthrough in reconstructive transplantation. Using tissue engineering techniques, VCAs can be freed of donor cells and customized for the recipient through perfusion-decellularization-recellularization. To develop these new technologies, a large-scale animal VCA model is necessary. Hence, swine fascio-cutaneous flaps, composed of skin, fat, fascia, and vessels, represent an ideal model for preliminary studies in VCA. Nevertheless, most VCA models described in the literature include muscle and bone. This work reports a reliable and reproducible technique for saphenous fascio-cutaneous flap harvest in swine, a practical tool for various research fields, especially vascularized composite tissue engineering.
Vascularized composite allografts (VCA) have revolutionized the treatment of hard-to-repair body part losses, such as hands, face, and penis1,2,3. Unfortunately, the first long-term outcomes4 have shown that lifelong administration of high-dose immunosuppressive agents can lead to severe collateral medical conditions, including diabetes, infections, neoplasia, and reno-vascular dysfunction5. Lately, expert VCA teams have had to manage the risk of chronic rejection leading to graft loss and perform the first face retransplantation cases6,7. Different strategies have been described to overcome the limitations of immunosuppression in VCA. The first relies on establishing long-term graft tolerance by inducing an immune mixed chimerism state in the allograft recipient8,9. The second involves de novo creation of a patient-specific graft via tissue engineering.
Recently, perfusion decellularization of biological tissues has generated native extracellular matrix (ECM) scaffolds, allowing the preservation of the vascular network and tissue architecture of whole organs10. Hence, the recellularization of these ECM with recipient-specific cells would create a customized graft free of immune constraints. In research on VCA bioengineering, multiple teams have decellularized and obtained such ECM preserving the entire architecture11,12,13. However, the recellularization process remains challenging and has not been successful in large animal models14,15. Developing these breakthrough technologies creates a need for reliable and reproducible large animal composite tissue models. Swine models represent the utmost choice in the bioengineering developmental pipeline, as porcine skin presents the closest anatomical and physiological characteristics to human skin16. The use of fascio-cutaneous flaps (FCF) is ideal during the first steps towards the creation of 'tailored' vascularized composite tissue grafts. Indeed, FCF is an elementary VCA model containing skin, fat, fascia, and endothelial cells. A description of swine myocutaneous flaps17 and osteomyocutaneous flaps18 can be found in the literature. Nonetheless, there is a lack of focus on fascio-cutaneous flaps harvest techniques.
Hence, this study aims to provide researchers with a detailed description of a swine saphenous FCF procurement technique and depict all the flap's characteristics for its use in many research fields, especially in vascularized composite tissue engineering.
All animals received human care following the National Institute of Health Guide for the Care and Use of Laboratory Animals. The Institutional Animal Care and Use Committee approved the experimental protocol (IACUC- protocol #2020N000015). Seven female Yorkshire pigs (20-25 kg) were used for all experiments.
1. Preoperative care
2. Intraoperative monitoring
3. Bilateral saphenous FCF procurement
Figure 1: Native and decellularized saphenous fascio-cutaneous flap. (A) Isolated skin flap with a 20 G angiocatheter inserted in the femoral artery, allowing to wash the flap from the blood and proceed with different experiments (angiography, perfusion decellularization). (B) Decellularized skin flap. Perfusion decellularization yielding white, acellular scaffolds after 10 days of detergent perfusion. H&E-stained full-thickness cross-sections of (C) native skin flap and (D) decellularized skin flap. Please click here to view a larger version of this figure.
This work on living animals was preceded by determining the saphenous perforasome on three cadaveric specimens (Figure 2). A colored filling solution was injected into the saphenous artery to opacify the specific vascular network coming from the artery. The solution is composed of 10 mL blue-colored glycerin agent mixed with 10 mL of the diluent agent (see Table of Materials). This generated a colored map of the skin vascularized by the saphenous artery and allowed drawing t...
This article describes a reliable and reproducible fasciocutaneous flap harvested on swine hindlimbs. Following this step-by-step surgical protocol will allow the procurement of two flaps on only one animal in less than 2 h. The most critical step of the surgery is the skeletonization of the vascular pedicle within the gracilis muscle fibers, which requires a thorough dissection by a skilled surgeon. Securing the skin to the fascia using cutaneous sutures is a crucial tip to avoid a shearing effect disrupting the perfora...
The authors have nothing to disclose.
This work was funded by Shriners Hospitals for Children grants #85127 (BEU and CLC) and #84702 (AA). The authors would like to thank the "Gueules Cassées" foundation for the salary support to the fellows involved in that project.
Name | Company | Catalog Number | Comments |
18 G angiocatheter | BD Insyte Autoguard | 381409 | |
20 G angiocatheter | BD Insyte Autoguard | 381411 | |
Adson Tissue Forceps, 11 cm, 1 x 2 Teeth with Tying Platform | ASSI | ASSI.ATK26426 | |
Atropine Sulfate | AdvaCare | 212-868 | |
Bipolar cords | ASSI | 228000C | |
Buprenorphine HCl | Pharmaceutical, Inc | 42023-179-01 | |
Dilating Forceps | Fine science tools (FST) | 18131-12 | |
Endotrachel tube | Jorgensen Labs | JO615X | size from 6 to 15mm depending on the pig weight |
Ethilon 3-0 16 mm 3/8 | Ethicon | MPVCP683H | |
Euthasol | Virbac AH | 200-071 | |
Heparin Lock Flush Solution, USP, 100 units/mL | BD PosiFlush | 306424 | |
Isoflurane | Patterson Veterinary | 14043-704-06 | |
Jewelers Bipolar Forceps Non Stick 11 cm, straight pointed tip, 0.25 mm tip diameter | ASSI | ASSI.BPNS11223 | |
Metzenbaum scissors 180 mm | B Braun | BC606R | |
Microfil blue | Flow tech | LMV-120 | |
Microfil dilution | Flow tech | LMV-112 | colored filing solution |
Monopolar knife | ASSI | 221230C | |
N°15 scalpel blade | Swann Morton | NS11 | |
Omnipaque | General Electric | 4080358 | contrast product |
Perma-Hand Silk 3-0 | Ethicon | A184H | |
Small Ligaclip | Ethicon | MCM20 | |
Stevens scissors 115 mm | B Braun | BC008R | |
Telazol | Zoetis | 106-111 | |
Xylamed (xylazine) | Bimeda | 200-529 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved